Industry: Health care Region: Spain Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
The company's main goal is to create technical solutions for autonomous and real-time physiological monitoring of chronic and frail patients. We will use vital signs and sweat biomarkers, combined with cloud-based processing and communication services, to provide cohesive digital biomarkers: metabolism (lactic acid and glucose) and ionic compounds, heart rate (HR), respiratory rate (RR), oxygen saturation (SpO2), arterial blood pressure (ABP), body TEMPerature (temp), physical activity (PA) and dehydration (DH).
In order to achieve these goals, the company has developed an advanced sweat monitoring device and a platform based on digital cloud, so that data can be collected, stored and processed by machine learning (ML) protocol, so as to infer the required digital biomarkers from the collected data and provide additional information.
Its research team has developed the technical basis of this technology, which is based on collecting human sweat, confining it in a microfluidic structure and guiding it into a multi-sensor module to test whether the production of sweat is suitable for analysis. Sweat will be updated in each cycle to ensure that the new measurement is not affected by the old sweat. This sweat skin connection provides a big data, which makes it possible to define the individual pattern of each chronic patient and promotes personalized digital therapy.